Public health and infectious disease experts said they were surprised and confused about the move, and questioned why the HHS did not offer any reasoning for its decision.

The University of Washington’s Helen Chu, a leading voice in the COVID-19 pandemic, said she’s worried about where the panel ...

The FDA approved mResvia for the prevention of RSV in people ages 18 to 59 years who are at increased risk for severe disease ...

The U.S. Food and Drug Administration expanded approval of Moderna Inc.'s (NASDAQ: MRNA) respiratory syncytial virus vaccine.

It starts with a sniffle. A mild cough. You tell yourself it’s just a cold—babies get those, right? But make no mistake. RSV ...

The number of Australians vaccinated against influenza is "worryingly low", health experts say, as new data reveal the winter ...

People in Northern Ireland are being reminded that a potentially life-saving vaccination aimed at protecting newborns and ...

Covid-19 infection rates have soared by more than 30 percent in the past two weeks as the new highly transmissible strain ...

Hospitalized flu patients given the antiviral drug oseltamivir (Tamiflu) are less likely to die in the hospital, be released ...

Queenslanders are rapidly falling ill as temperatures plummet, with Covid-19 infections soaring 30 per cent in a fortnight ...

The study found that 15 percent of preschool-aged children with confirmed COVID infection are suffering from Long COVID.

Meanwhile, Sanofi has pointed to Beyfortus’ 75% reduction in the incidence of MALRI versus Enflosia’s figure of 60%. The ...